CVE-2021-3305
Beijing Feishu Technology Co., Ltd Feishu v3.40.3 was discovered to contain an untrusted search...
Beijing Feishu Technology Co., Ltd Feishu v3.40.3 was discovered to contain an untrusted search path vulnerability.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
Beijing Feishu Technology Co., Ltd Feishu v3.40.3 was discovered to contain an untrusted search path vulnerability.
- Record
CVE-2021-3305- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - Weakness
- CWE-426
- Updated
- 2026-11-02
CVE List
Beijing Feishu Technology Co., Ltd Feishu v3.40.3 was discovered to contain an untrusted search path vulnerability.
- Record
CVE-2021-3305- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - Weakness
- CWE-426
- Updated
- 2026-11-02
EUVDEUVD-2021-26639
Beijing Feishu Technology Co., Ltd Feishu v3.40.3 was discovered to contain an untrusted search path vulnerability.
- Record
EUVD-2021-26639- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-38gp-2mrc-f9cj
Beijing Feishu Technology Co., Ltd Feishu v3.40.3 was discovered to contain an untrusted search...
Beijing Feishu Technology Co., Ltd Feishu v3.40.3 was discovered to contain an untrusted search path vulnerability.
- Record
GHSA-38gp-2mrc-f9cj- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - Weakness
- CWE-426, CWE-428
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2021-3305 is a high vulnerability (CVSS 7.8) in Feishu, published October 18, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.35%, the 28th percentile. No source names a fixed version.